comparemela.com

Latest Breaking News On - Genitourinary cancers - Page 3 : comparemela.com

The Way Cancer Has Shaped Me

Looking back on my experience with testicular cancer at a young age, I realize that cancer didn't define me it helped shape me.

Coach macGenitourinary cancersTesticular cancer

Dr Zhang on the Implications of Findings From the KEYNOTE-564 Trial in RCC

Tian Zhang, MD, MHS, discusses the implications of subgroup analyses from the KEYNOTE-564 trial in patients with renal cell carcinoma.

Department of internal medicineHaroldc simmons comprehensive cancer centerInternational kidney cancer symposiumUt southwestern medical centerTian zhangInternal medicineComprehensive cancer centerMedical centerKidney cancer symposiumCancers symposiumUt southwestern haroldc simmons comprehensive cancer centerOnclive tvGenitourinary cancersRenal cell carcinoma

Dr Garmezy on Choosing an IO/TKI Treatment Regimen in ccRCC

Benjamin Garmezy, MD, discusses in when to choose an IO/TKI regimen for the treatment of patients with ccRCC.

United statesBenjamin garmezySarah cannon research instituteGenitourinary researchTennessee oncologyGenitourinary cancersOnclive tvSarah cannon research institute at tennessee oncology

Dr McGregor on Sacituzumab Govitecan Plus Enfortumab Vedotin in Treatment-Resistant mUC

Bradley McGregor, MD, discusses the next steps for investigating cabozantinib plus atezolizumab in patients with advanced renal cell carcinoma.

Bradleya mcgregorLank centerDana farber cancer instituteHarvard medical schoolGenitourinary oncologyAntibody drug conjugateOnclive tvGenitourinary cancersRenal cell carcinomaEnfortumab vedotinSacituzumab govitecanDad trial

Lenvatinib/Pembrolizumab Maintained Beneficial Outcomes When Evaluated by Tumor Size in RCC

Lenvatinib/pembrolizumab demonstrated efficacy irrespective of tumor burden in advanced renal cell carcinoma in the overall patient population of the phase 3 CLEAR study.

United statesLenvatinib lenvimaUniversity hospital essenInterdisciplinary genitourinary oncologySubgroup analysisWestern europeNorth americaImmunotherapy in gu cancersGenitourinary cancersImmuno oncology

vimarsana © 2020. All Rights Reserved.